I. Dokli et al. / Tetrahedron: Asymmetry 24 (2013) 785–790
789
acryloyl chloride 6 (490 mg, 1.92 mmol). The mixture was stirred
overnight at room temperature and then poured onto crushed
ice, after which CH2Cl2 (20 mL) was added. The reaction mixture
was acidified with 1 M aq HCl. The layers were separated and the
aqueous phase extracted with CH2Cl2 (3 ꢁ 50 mL). The combined
organic extracts were dried over Na2SO4, filtered, and concentrated
under vacuum. The crude product was a mixture of 13a and 13b
(3:1). The residue was purified by column chromatography on sil-
ica gel (diethyl ether/CH2Cl2 = 1/1) to afford ester 13a (330 mg,
60%) as a colorless solid, and 13b (160 mg) as a white solid. Com-
pound 13a: 1H NMR (300 MHz, CDCl3): d = 0.05 (s, 3H), 0.08 (s, 3H),
0.83 (s, 9H), 2.11–2.12 (m, 2H), 2.33 (s, 3H), 2.41–2.44 (m, 1H), 2.56
(d, 1H, J = 11.8 Hz), 2.72 (s, 1H), 3.89 (s, 3H), 4.04–4.08 (m, 1H),
4.86–4.87 (m, 1H), 5.43–5.45 (m, 1H), 6.43 (d, 1H, J1 = 15.8 Hz),
7.07–7.16 (m, 3H), 7.69 (d, 1H, J1 = 15.8 Hz). 13C NMR (75 MHz,
CDCl3): d = ꢀ5.56, 17.41, 20.08, 25.07, 37.00, 40.54, 55.48, 65.46,
66.10, 71.49, 73.75, 110.98, 116.79, 120.87, 122.85, 132.55,
141.32, 144.91, 151.02, 164.89, 168.18, 176.75.
aqueous NaHCO3 (30 mL). The aqueous layer was extracted once
with EtOAc (30 mL). The combined organic extracts were dried
over Na2SO4, filtered, and concentrated under vacuum. Crude prod-
uct was recrystallized from EtOAc/n-hexane = 1/5 to afford com-
pound 16 (1.28 g, 76% from quinic acid) as a white solid. NMR
data are in accordance with the literature data.16
4.11. (1R,3R,4S,5R)-5-[3-(4-Acetoxy-3-methoxyphenyl)-acryloyl
oxy]-3,4-O-(20,30-dimethoxybutane-20,30-diyl)-1-hydroxycyclo-
hexanecarboxylic acid methyl ester 17
To a solution of 3,4-BBA protected methyl quinate 16 (750 mg,
2.34 mmol) and DMAP (30 mg, 0.23 mmol) in CH2Cl2 (20 mL) were
added pyridine (2 mL) and 3-(4-acetoxy-3-methoxyphenyl)-acry-
loyl chloride 3 (894 mg, 3.51 mmol). The mixture was stirred over-
night at room temperature and then acidified with 1 M aq HCl. The
layers were separated and the aqueous phase extracted with
CH2Cl2 (3 ꢁ 50 mL). The combined organic extracts were dried over
Na2SO4, filtered, and concentrated under vacuum. The residue was
purified by column chromatography on silica gel (diethyl ether/
CH2Cl2 = 1/1) to afford ester 17 (1.09 g, 86%) as a white solid. 1H
NMR (300 MHz, CDCl3): d = 1.31 (s, 3H), 1.32 (s, 3H), 1.99–2.34
(m, 4H), 2.35 (s, 3H), 3.23 (s, 1H), 3.29 (s, 3H), 3.33 (s, 3H), 3.75
(dd, 1H, J1 = 3.2 Hz, J2 = 10.2 Hz), 3.81 (s, 3H), 3.91 (s, 3H), 4.40–
4.99 (m, 1H), 5.38–5.41 (m, 1H), 6.48 (d, 1H, J = 15.9 Hz), 7.06–
7.16 (m, 3H), 7.69 (d, 1H, J = 15.9 Hz). 13C NMR (75 MHz, CDCl3):
d = 17.12, 17.35, 20.08, 36.20, 38.23, 47.44, 47.54, 52.66, 55.50,
62.30, 69.35, 70.74, 74.14, 99.12, 99.65, 110.74, 118.16, 121.06,
122.67, 133.04, 140.98, 143.95, 150.91, 165.91, 168.16, 174.93.
Compound 13b: 1H NMR (300 MHz, CDCl3): d = 0.05 (s, 3H), 0.08
(s, 3H), 0.83 (s, 9H), 2.26–2.32 (m, 1H), 2.32 (s, 3H), 2.33 (s, 3H),
2.33–2.46 (m, 1H), 2.72 (d, 1H, J = 11.5 Hz), 3.07–3.15 (m, 1H),
3.86 (s, 3H), 3.88 (s, 3H), 4.11–4.19 (m, 1H), 4.91–4.96 (m, 1H),
5.45–5.49 (m, 1H), 6.41 (d, 1H, J1 = 15.9 Hz), 6.45 (d, 1H,
J1 = 15.9 Hz), 7.03–7.16 (m, 6H), 7.67 (d, 2H, J1 = 15.9 Hz). 13C
NMR (75 MHz, CDCl3): d = ꢀ5.60, ꢀ5.57 17.41, 20.09, 25.07,
34.01, 37.19, 55.48, 55.49, 65.34, 66.47, 73.80, 76.12, 110.86,
110.92, 116.56, 116.79, 120.99, 121.02, 122.84, 122.86, 132.41,
132.57, 141.32, 141.44, 144.95, 145.50, 151.03, 164.31, 164.86,
168.12, 168.15, 171.55.
4.9. 4-O-Feruloylquinic acid 2
4.12. 5-O-Feruloylquinic acid 3
To a solution of ester 13a (1.0 g, 1.97 mmol) in THF (15 mL) was
added 1 M aq HCl (60 mL), after which the mixture was stirred for
5 days at room temperature. The solution was saturated with solid
NaCl and the aqueous phase extracted with EtOAc (3 ꢁ 40 mL). The
combined organic extracts were dried over Na2SO4, filtered, and
concentrated under vacuum. The residue was purified by column
chromatography on silica gel (EtOAc) and then recrystallized from
the mixture of THF/diisopropyl ether to afford 2 (260 mg, 36%) as a
white powder. NMR analysis showed that the obtained powder
was an adduct with THF in a molar ratio 4:1 = 2:THF. Next,
100 mg of this adduct was dissolved in CH3OH and the solvent
was again evaporated to provide THF free product 2. NMR data
were in accordance with the literature data.17 1H NMR (300 MHz,
methanol-d4): d = 1.99–2.28 (m, 4H), 3.92 (s, 3H), 4.27–4.35 (m,
2H), 6.47 (d, 1H, J = 15.9 Hz), 6.84 (d, 1H, J = 8.4 Hz), 7.12 (dd, 1H,
J1 = 1.8 Hz, J2 = 8.4 Hz), 7.22 (d, 1H, J = 1.8 Hz), 7.73 (d, 1H,
J = 15.9 Hz). 13C NMR (75 MHz, methanol-d4): d = 37.04, 41.31,
55.06, 64.16, 68.24, 75.17, 77.92, 110.43, 114.38, 115.11, 122.63,
126.47, 145.56, 147.98, 149.20, 167.53, 175.88. HRMS (MALDI):
m/z: calcd for C17H20O9Na [M+Na+] 391.0999; found: 391.0999.
To a solution of ester 17 (1.4 g, 2.60 mmol) in THF (20 mL), 1 M
aq HCl (60 mL) was added. The mixture was stirred for 4 days at
room temperature. The solution was saturated with solid NaCl
and aqueous phase extracted with EtOAc (3 ꢁ 40 mL). The com-
bined organic extracts were dried over Na2SO4, filtered, and con-
centrated under vacuum. The residue was recrystallized twice
from the mixture of THF/diisopropyl ether to afford 3 (660 mg,
69%) as
a
white powder. 1H NMR (300 MHz, methanol-d4):
d = 1.94–2.22 (m, 4H), 3.67 (dd, 1H, J1 = 3.3 Hz, J2 = 8.5 Hz), 3.92
(s, 3H), 4.14–4.22 (m, 1H), 5.37–5.41 (m, 1H), 6.42 (d, 1H,
J = 15.9 Hz), 6.83 (d, 1H, J = 8.1 Hz), 7.09 (dd, 1H, J1 = 1.9 Hz,
J2 = 8.1 Hz), 7.21 (d, 1H, J = 1.9 Hz), 7.67 (d, 1H, J = 15.9 Hz). 13C
NMR (75 MHz, methanol-d4): d = 35.35, 40.18, 55.05, 66.88,
71.65, 73.46, 74.01, 110.33, 114.84, 115.07, 122.59, 126.57,
145.26, 147.96, 149.08, 167.56, 176.89. HRMS (MALDI): m/z: calcd
for C17H20O9Na [M+Na+] 391.0999; found: 391.0995. ½a 2D5
¼ þ10:9
ꢂ
(c 0.64, CH3OH).
Acknowledgments
½
a 2D5
ꢂ
¼ ꢀ55:7 (c 0.79, CH3OH).
We thank the Ministry of Science, Education and Sports of the
Republic of Croatia (Grant no. 098-0982933-2908). This work is
also a part of a joint project with illycaffè s.p.a in the framework
of the project: ‘Nutrigenomica e consumo di caffè: effetti fisiologici,
genetica del gusto e genetica della pianta’ partially supported by
the POR-FESR 2007-2013 Regione Autonoma Friuli Venezia Giulia,
Italy.
4.10. (1S,3R,4R,5R)-3,4-O-(20,30-Dimethoxybutane-20,30-diyl)-1,5-
dihydroxycyclohexanecarboxylic acid methyl ester 16
To a suspension of
D-(ꢀ)-quinic acid (1 g, 5.2 mmol) in MeOH
(30 mL), ( )-10-camphorsulfonic acid (12 mg, 0.052 mmol) was
added. Reaction mixture was then refluxed overnight. After cool-
ing, 2,2,3,3-tetramethoxybutane 15 (927 mg, 5.7 mmol), trimethyl
orthoformate (2.6 mL, 0.024 mol), and ( )-10-camphorsulfonic
acid (12 mg, 0.052 mmol) were added and mixture again refluxed
overnight. Powdered NaHCO3 (0.1 g) was added to the cold reac-
tion mixture. Solution was concentrated under reduced pressure
and the residue partitioned between EtOAc (30 mL) and saturated
References